Earnings Review: AstraZeneca Increases Profit Outlook, Reports 17% EPS Growth
November 09, 2023 at 07:12 AM EST
AstraZeneca reported an EPS of $1.73 for Q3 2023 and $5.8 for 9M 2023.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |